(Q33684930)

English

Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

0 references

Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J Schmitt

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

L von Kobyletzki

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

A Svensson

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

C Apfelbacher

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

0 references

publication date

23 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

164

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

415-428

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Atopic Dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Atopic dermatitis and the atopic march

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Psychiatric comorbidity in adult eczema.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Infant-onset eczema in relation to mental health problems at age 10 years: results from a prospective birth cohort study (German Infant Nutrition Intervention plus).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

The burden of atopic dermatitis: impact on the patient, family, and society

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Clinical practice. Atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Skin barrier function, epidermal proliferation and differentiation in eczema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

What are the best outcome measurements for atopic eczema? A systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

A comparison of methods to detect publication bias in meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Efficacy and safety of fluticasone propionate 0.005% ointment in the long-term maintenance treatment of children with atopic dermatitis: differences between boys and girls?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Topical corticosteroids in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Twice-weekly topical corticosteroid therapy may reduce atopic dermatitis relapses

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

What is meant by a "flare" in atopic dermatitis? A systematic review and proposal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a pre-screening tool for studies.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

If nothing goes wrong, is everything all right? Interpreting zero numerators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2010.10030.X

21 January 2018

Identifiers

10.1111/J.1365-2133.2010.10030.X

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33684930&oldid=1534728524"